Jane Street’s Electra Therapeutics, Inc. Common stock ETRA Stock Holding History

Jane Street’s Portfolio ETRA Stock Details ETRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$672K	Buy	+59,752	New	+$735K	﹤0.01%	7340

Other funds holding ETRA

EQT Fund Management Luxembourg $947M AUM 19.95% 1-Year Est. Return

Sanofi Paris, France $630M AUM 104.49% 1-Year Est. Return

Jefferies Financial Group New York $13.5B AUM 36.68% 1-Year Est. Return

JP Morgan Chase New York $1.84T AUM 33.86% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $179B AUM 29.92% 1-Year Est. Return

Ensign Peak Advisors Salt Lake City, Utah $60.6B AUM 33.98% 1-Year Est. Return

Monashee Investment Management Boston, Massachusetts $33.4M AUM 92.4% 1-Year Est. Return

Squarepoint New York $90.8B AUM 26.98% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Quantbot Technologies New York $2.78B AUM 9.9% 1-Year Est. Return

Jane Street's ETRA Position: Q3 2026 in Review

Jane Street opened a new position in Electra Therapeutics, Inc. Common stock (ETRA) in Q3 2026: 59,752 shares worth $672K. The stake represents ﹤0.01% of the portfolio and ranks #7340 among its holdings.

14 funds tracked by Wall St. Rank hold ETRA as of Q3 2026.

Jane Street held 59,752 shares of Electra Therapeutics, Inc. Common stock worth $672K as of Q3 2026.
Electra Therapeutics, Inc. Common stock was a new Jane Street position in Q3 2026.
Electra Therapeutics, Inc. Common stock made up ﹤0.01% of Jane Street's portfolio in Q3 2026, its #7340 holding.
14 funds tracked by Wall St. Rank held Electra Therapeutics, Inc. Common stock as of Q3 2026.

Based on Jane Street's 13F filing for Q3 2026, filed 12 Nov 2026.